Eur J Pediatr (2000) 159: 555±562
Ó Springer-Verlag 2000
REVIEW
Lieven Lagae
Cortical malformations: a frequent cause of epilepsy in children
Received: 25 November 1999 and in revised form 10 January 2000 / Accepted: 10 January 2000
Abstract In this review, a simpli®ed scheme for classi®cation of cortical malformations is introduced and illustrated based on the work of Barkovich et al. [8]. Detailed MRI studies identify cortical malformations as a major cause of epilepsy in children. Two aspects that are becoming increasingly important for the paediatrician are emphasised. First, knowledge of the genetic background of cortical malformations is necessary for appropriate genetic counselling. Although the majority of cortical malformations occur sporadically, recent studies have shown a familial pattern in speci®c epilepsy syndromes associated with cortical malformations. Second, the epilepsy becomes refractory to the common anti-epileptic drugs in many patients with cortical malformations so that epilepsy surgery should be considered. In this respect, the paediatrician can play a pivotal role in referring candidate patients for further specialised assessment. Conclusion The input of the paediatrician will become crucial to link clinical, genetic and neuro-imaging data in children with the great variety of possible cortical malformations. Key words Epilepsy á Cortical malformations á Migration disorders á Magnetic resonance imaging á Brain development Abbreviations MRI magnetic resonance imaging á EEG electro-encephalogram á PET positron emission tomography á CT computed tomography á FISH ¯uorescence in situ hybridisation Introduction
The introduction of MRI techniques in paediatric neurology has substantially increased our knowledge about possible abnormalities during cortical development. An increasing number of cortical malformations has been reported in recent years [7, 8, 9, 10, 22, 34, 35]. Almost all of these developmental abnormalities can present with epilepsy, behavioural, psychiatric or cognitive problems. In many children with epilepsy, cortical abnormalities are identi®ed if studied with detailed MRI protocols [46]. Two clinically relevant aspects of cortical malforL. Lagae (&)1 Department of Paediatric Neurology, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
mations are emphasised in this review. First, the genetic background of several cortical malformations is now better understood so that genetic counselling becomes a mandatory part in the overall assistance of a family with an epileptic child. Second, the epilepsy becomes refractory to the common anti-epileptic drugs in many epileptic children with cortical malformations. Therefore, at some point during their illness, epilepsy surgery should be considered. A thorough understanding of the nature and the location of the cortical malformation serves as a guideline for deciding on eligibility for epilepsy surgery and also for predicting the possible outcome thereafter [70]. e-mail:
[email protected], Tel.: +32-16-343834; Fax: +32-16-343842 1
Holder of UCB-Chair in Cognitive Dysfunctions in Children
556
In this review, we will describe the most common types of cortical malformations, following the classi®cation scheme developed by Barkovich et al. [7, 8]. For the practising paediatrician, it is important to become familiar with this classi®cation and with the terminology used. As will be pointed out, this classi®cation scheme will help in outlining the work-up in a child with a cortical malformation. Stages in cortical development: the basis for classi®cation of cortical malformations
At any stage during prenatal development, intrinsic genetic or extrinsic environmental factors may disturb normal cortical development. It is still believed that especially the timing and to a lesser degree the nature of the `insult' will determine the extent and the severity of the cortical malformation. Abnormalities during the earliest stages of brain development, namely the dorsal and ventral induction periods, are beyond the scope of this review. Malformations originating from this early period are incompatible with life or cause severe neurological syndromes in which epilepsy usually is only a `minor' symptom. The best known abnormalities in this category are anencephaly and holoprosencephaly. Dierent genes for holoprosencephaly have been identi®ed. They play an important role in normal forebrain development [68]. In the ®rst weeks of pregnancy, neuronal proliferation and dierentiation of the neuroblasts in the periventricular region starts. At this early vulnerable stage, interruption of normal development or abnormal proliferation can cause abnormalities involving extensive parts of the brain as seen in tuberous sclerosis (TS) and hemimegalencephaly. However, also very focal cortical dysplasia can originate from this prenatal period. The neuroblasts start to migrate around the post-menstrual age of 6±7 weeks, leaving the periventricular region and ®nding their way to the cortex, guided by radial glial ®bres [53]. Abnormalities can occur at any of the migration stages: failure to migrate (e.g. subependymal heterotopia), arrest during migration (e.g. band heterotopia, subcortical heterotopia) or formation of an abnormal cortex (e.g. lissencephaly). Once the young neurons reach the cortex, a long period of further differentiation and synapse formation begins. Polymicrogyria following an intrauterine cytomegalovirus infection is a notable example of a post-migrational cortical malformation. Barkovich et al. [8] proposed a classi®cation scheme based on these three major developmental stages: the neuronal and glial proliferation period, the migration period and the post-migration period. The other relevant parameter used in this scheme is the distinction between generalised and focal abnormalities. A simpli®ed overview of their classi®cation is given in Table 1. The most common disorders will be discussed in the next sections, with emphasis on genetic background and epilepsy. Table 2 gives an overview of
the known genetic abnormalities in the cortical malformations that are discussed in this review text. Abnormal neuronal and glial proliferation
Distinction should be made between neoplastic and nonneoplastic lesions. In the latter category, TS and hemimegalencephaly are classical examples. TS is well known in paediatric practice because of its multi-organ involvement. TS, an autosomal dominant disorder with variable expression, can be considered as the result of a fundamental abnormality in suppressor gene regulation. This syndrome is linked to chromosome 9q34.3 (TSC1 gene, MIM 191100) or 16p13.3 (TSC2 gene, MIM 191092) [28, 39, 66]. These genes code for hamartin and tuberin respectively and are both involved in cellular dierentiation, tumour suppression and intracellular signalling [16]. The key intracranial lesions are cortical tubers, characterised by a disorganised cortex with a mixture of atypical neuron-like cells, neuroepithelial cells and other bizarre glial cells. The adjacent white matter is also abnormal. Other possible malformations in TS patients are subependymal nodules, giant-cell astrocytomas and white matter lesions. The incidence of epilepsy is very high in children with TS. Infantile spasms are very frequent in infancy, inasmuch that TS should be considered in the dierential diagnosis in any infant presenting with infantile spasms. Until recently, TS was a relative contra-indication for epilepsy surgery. However, if seizure symptomatology is concordant with ictal EEG monitoring and MRI data, these children can be considered for surgery [33]. In this respect, Chugani et al. [15] recently showed that positron emission tomography is a sensitive tool to dierentiate active epileptogenic tubers from non-epileptic ones. Hemimegalencephaly is a rather infrequent abnormality with a great variety in clinical presentation. In the aected enlarged hemisphere, dierent cortical malformations can be found in dierent areas, illustrating the severe disruption of hemispheric organisation: pachygyria, focal cortical dysplasia, nodular heterotopia etc. The white matter is usually involved and the ventricular system is enlarged. Clinically, the child presents with a hemiparesis, which is often surprisingly mild. Further examination can show a hemi-anopsia. Mental retardation is also very variable. The hemimegalencephaly can be an isolated ®nding or part of a neurocutaneous syndrome: e.g. epidermal naevus syndrome (MIM 601359) [67], hypomelanosis of Ito (MIM 146150) [11], or neuro®bromatosis. Partial epilepsy is very common and epilepsy surgery can be of great bene®t in refractory cases. In children with a severe hemiplegia, a functional hemispherectomy is proposed [2]. In others, more limited tailored cortical resections can be considered, if seizures and functional neuro-imaging indicate a very focal onset of the seizures. Figure 1 illustrates the MRI of a 16-year-old boy with partial hemimegalencephaly. He presented with psychomotor retardation, hemipare-
557 Table 1 Simpli®ed classi®cation of cortical malformations [8] Cortical malformations Abnormal neuronal/glial proliferation
Abnormal neuronal migration
Abnormal cortical organisation
Generalised
Focal/multifocal
Generalised
Focal/multifocal
Generalised
Focal/multifocal
Microlissencephaly
Non-neoplastic TS Hemimegalencephaly Focal cortical dysplasia with balloon cells Neoplastic Dysembryoplastic neuroepithelial tumour Ganglioglioma, gang liocytoma
Lissencephaly type 1, Agyriapachygyria spectrum Lissencephaly type 2 Heterotopia Subependymal Subcortical Subpial
Focal agyriapachygyria Unlayered polymicrogyria Focal heterotopia
Layered polymicrogyria
Polymicrogryia Schizencephaly Focal cortical dysplasia without balloon cells Microdysgenesis
Table 2 Genetic background in selected cortical malformation syndromes Early abnormalities Holoprosencephaly Abnormal neuronal and glial proliferation TS Abnormal neuronal migration Lissencephaly type 1 Isolated lissencephaly, Miller Dieker X linked lissencephaly X linked subcortical band heterotopia Lissencephaly type 2 Muscle-eye-brain disease Fukuyama congenital muscular dystrophy Heterotopia Bilateral periventricular nodular heterotopia Abnormal cortical organisation Familial bilateral schizencephaly
Chr 7:SHH Chr 13:ZIC2 Chr 2:SIX3
Homeobox genes
Chr 9q34.3:TSC1 Chr 16p13.3:TSC2
Hamartin Tuberin
Chr 17p13.3:LIS1 Chr Xq22.3:XLIS Chr Xq22.3:XLIS-SBHX
Platelet activating factor acetylhydrolase Doublecortin Doublecortin
Chr 1p32±34 Chr 9q31±33
Fukutin
Chr Xq28
Filamin 1
Chr 10q26.1:EMX2
Homeobox gene
sis and refractory partial epilepsy. The right hemisphere is enlarged, especially in the posterior parts with irregular cortex (pachygyria), white matter changes and hyperintense spots lining the occipital pole of the ventricle (heterotopia). Low-grade neoplastic lesions can also present with epilepsy. The distinction with focal cortical dysplasia is sometimes dicult on standard MRI. Two entities are frequent: the ganglioglioma/gangliocytoma and the dysembryoplastic neuroepithelial tumours [17, 23]. On MRI, they show up as an ill-de®ned lesion, involving grey and white matter. Their predilection location is the (anterior) temporal pole which makes this lesion very epileptogenic. Many patients therefore present with complex partial seizures with typical temporal lobe characteristics. Anterior temporal lobectomy is proposed when epilepsy becomes refractory or when tumour growth causes other neurological symptoms. It should be emphasised that tumour resection alone not always suces to stop the seizures [40, 42].
Abnormal neuronal migration
The majority of the abnormalities in this category belong to two major entities: the agyria-pachygyria spectrum or the heterotopia spectrum. The best known abnormality is the classical lissencephaly type 1 picture with a broad (>10 mm) smooth cortex with only the central sulcus visible. Pathologically, the cortex has four cortical layers instead of six. In the white matter, heterotopic clusters of neurons can be found; the corpus callosum is hypoplastic and the ventricles are dysmorphic. This is the extreme of the wide agyria-pachygyria spectrum [1]. Agyria refers to a thick cortex with no visible sulci, while pachygyria indicates a thick cortex but with some discernible sulci. Six grades are de®ned. Grade 1 indicates diuse agyria as seen in classical lissencephaly. In grade 2, some sulci are seen in the frontal and temporal lobes. Grade 3 shows better developed but still abnormal gyri in the frontal lobes.
558
Fig. 1 MRI of a 16-year-old boy with partial hemimegalencephaly of the right hemisphere. Dierent cortical malformations are recognised; see text for further explanation
Typically, agyria is found in the posterior parts of the brain. Grade 4 is characterised by diuse pachygyria. Grade 5 is characterised by a combination of pachygyria and subcortical band heterotopia (see below). Grade 6 refers to subcortical band heterotopia. Two subtypes are de®ned for all grades: the A subtype indicates more severe abnormalities (agyria) in the posterior parts; the B subtype indicates more severe abnormalities in the anterior parts of the brain. Figure 2 is an example of a grade 3A abnormality. This 14-year-old boy has the Lennox-Gastaut syndrome. Both sporadic [38] and genetically determined cases have been described. In classical lissencephaly (grades 1 to 3), a deletion can be found on chromosome 17p13.3 in many patients [14, 44, 55]. The LIS-1 gene codes for a brain platelet activating factor acetylhydrolase isoform Ib [37]. In a study of Fogli et al. [26], a ®rst correlation between the amount of intracellular LIS-1 protein and the severity of the clinical picture was illustrated. In the Miller Dieker syndrome (MIM 247200), classical lissencephaly is associated with (sometimes subtle) facial dysmorphic features: long thin upper lip, micrognathia, malformed ears, upturned nares, broad nasal bridge with epicanthal folds, bitemporal hollowing, abnormal irides and tortuous fundal vessels [20, 47]. Fluorescence in situ hybridisation testing shows 17p13.3 deletions in more than 90%. If a deletion is found, parental studies should be performed to ®nd balanced translocations. Lissencephaly always presents with a severe clinical picture: hypotonia at birth, feeding problems, overall delay in psychomotor development and epilepsy. Epilepsy starts early on and usually evolves into a catastrophic epileptic syndrome characterised by refractory myoclonic seizures, infantile spasms or other seizure types. In these cases, epilepsy surgery is of little bene®t because of the widespread involvement. In selected cases, palliative corpus calloso-
Fig. 2 Grade 3A lissencephaly in a 14-year-old boy. Some rudimentary sulci are seen in the frontal lobes and agyria in the posterior parts
tomy can be proposed [43]. Children ultimately develop spastic quadriplegia, blindness and inability to communicate. The mortality rate is still very high at a young age. The clinical picture in the other forms of agyria-pachygyria depends on the extent and the location of the abnormal cortical regions. The incidence of epilepsy is very high in all cases with pachygyria and is usually dicult to control. Unless the pachygyria are very focal, there is little indication for epilepsy surgery. Subcortical band heterotopia should be considered as the result of an arrested migration leaving a band of neurons in the white matter (MIM 300067) [3, 48]. Subcortical band heterotopia, also called double cortex syndrome, is almost exclusively seen in females and is caused by an X linked abnormality (Xq22.3). Females with subcortical band heterotopia are thus heterozygotes for the disease. Surviving males present with classical lissencephaly [19, 45, 51, 57]. The gene product is called doublecortin, a protein with an unknown function [31]. In any male child with lissencephaly, one should therefore look for the 17p13.3 deletion and also perform MRI in the mother to exclude subcortical band heterotopia. In subcortical band heterotopia, symptoms are usually less severe with, e.g. only mild mental retardation. Even asymptomatic cases have been described. In one study, the degree of mental retardation was correlated with the band thickness illustrating that a thicker band is the result of a more severe insult during migration with more repercussion on brain functioning [6]. If seizures occur in subcortical band heterotopia, they commonly start beyond infancy. Figure 3 is an illustrative example of a double cortex syndrome in a 9-year-old girl with severe mental retardation. She was admitted for aggressive outbursts. There were no clinical seizures, although long-term video-EEG monitoring showed epileptic spikes over the frontal regions.
559
Fig. 3 Double cortex syndrome in a 9-year-old girl. A thick grey matter band is seen in between the ventricles and the cortex. See text for clinical details
Less known is the lissencephaly type 2, also called cobblestone lissencephaly because of the irregular cortex abnormalities. The cortex is thick with irregular grouping of neurons and gliovascular scars with areas of heterotopia. A typical feature is also the involvement of the cerebellum showing cortical dysplasia and other cortical abnormalities [18]. A key feature of type 2 lissencephaly is the possible association with neuromuscular diseases. Type 2 lissencephaly can be part of the WalkerWarburg syndrome (MIM 236670), muscle-eye-brain disease (MIM 253280) and Fukuyama congenital muscular dystrophy (MIM 253800) [21, 29, 36, 58, 65, 70]. Heterotopia refers to a never started or arrested migration of groups of neurons. Heterotopia can be widely distributed throughout the brain or very focal. Depending on the location of the abnormal neuronal groups, one can distinguish subependymal, subcortical or subglial heterotopia [5, 27]. Recent studies have illustrated the intrinsic epileptogenic characteristics of heterotopic tissue explaining the high incidence of epilepsy in children with heterotopia [30, 50, 59]. Periventricular nodular heterotopia is a rather well de®ned syndrome, with heterotopic nodules lining the lateral ventricles (MIM 300049). It can occur sporadically, but X linked transmission has been described (Xq28, coding for ®lamin 1 [27]). It has also been described in association with other syndromes such as the Aicardi syndrome (MIM 304050) [22, 34, 60]. Focal or multifocal heterotopia can be seen in some metabolic diseases such as Zellweger syndrome (MIM 214100) [24].
derdiagnosed. Three dierent abnormalities will be discussed in this section: focal cortical dysplasia, polymicrogyria and schizencephaly. Actually, these abnormalities can also be seen as a result of an earlier insult, thus belonging to the abnormal neural and glial proliferation group. Especially schizencephaly remains dicult to classify. MRI and neuropathology can dierentiate between an earlier insult and a later insult. This is an important issue because insults occurring later in pregnancy are more likely to be due to extrinsic insults such as prenatal infections. Focal cortical dysplasia is a localised abnormality with changes in the normal architecture of the cortex [61, 63]. Sometimes underlying white matter changes accompany the cortical abnormality. Type 1 cortical dysplasia refers to a post-migration disorder without abnormal balloon cells. Type 2 cortical dysplasia is a true abnormality in proliferation of the neuronal and glial cells. In this type, large abnormal cells can be recognised (balloon cells) [13]. White matter changes are much more frequent in type 2 than in type 1 cortical dysplasia. The delineation of type 2 lesions from the lesions seen in TS is sometimes dicult. The incidence of epilepsy is very high in children with cortical dysplasia and usually starts later in the ®rst or early second decade [54]. In refractory cases with perfect concordance between ictal symptomatology, anatomical and functional neuro-imaging, resection surgery can reduce or stop the epilepsy [49, 52]. Success rate of epilepsy surgery however is determined by the possible presence of other dysplastic regions in the brain that are not recognised at the MRI level (`microdysgenesis'). Figure 4 shows a focal cortical dysplasia in the right parietal region in a 10-year-old boy. He presented with complex partial seizures at the age of 6 years. Secondary generalisation
Abnormal cortical organisation
Malformations due to an abnormal cortical organisation in late pregnancy have long been unrecognised and un-
Fig. 4 Focal cortical dysplasia in the right parietal area in a 10year-old boy. See text for clinical details
560
could be treated successfully with anti-epileptic drugs but the `auras' still occur at a frequency of about ®ve per week. Polymicrogyria is a complex malformation with an excess of sulci and cortical foldings in parts of the brain. CT scan of the brain can completely overlook the abnormality. With MRI, the abnormality is seen as a thick cortex. In other cases, the excess of sulci can be recognised [35]. Here also, two types are distinguished referring to the origin of the abnormality. In the postmigration type, individual layers of the cortex can still be recognised: layered polymicrogyria. In the type that originates from the migration period, individual layers can no longer be recognised: unlayered polymicrogyria [25]. Layered polymicrogyria can be diuse or follow arterial boundaries [56]. Therefore, it is believed that perfusion failure and/or hypoxia can cause this abnormality in pregnancy due to infection, carbon monoxide intoxication or severe trauma etc. Cytomegalovirus infection is a notable example in this respect [62]. A syndrome of bilateral perisylvian polymicrogyria is increasingly recognised, clinically characterised by bulbar signs, speech problems, mental retardation and epilepsy (MIM 260980) [41, 64]. In schizencephaly, there is a unilateral or bilateral cleft between the cortex and the ventricle. The cleft can be `open' with cerebrospinal ¯uid between the two lips of the cleft, or `closed' with adjacent cleft lips. The cleft is usually bordered by abnormal polymicrogyric or heterotopic cortex. One hypothesis is that the cleft is the result of a circulatory failure interrupting the cortical mantle. The cortical abnormalities in the cleft lips can then be considered as a sort of late and inadequate repair mechanism. In some cases with bilateral clefts, a de®cit in the homeobox gene EMX2 has been described (MIM 600035) [12, 32]. With the introduction of MRI, it became clear that schizencephaly has a very variable clinical presentation. Most children with schizencepaly nevertheless present with a central motor de®cit (hemiplegia), mental retardation and epilepsy [4]. Symptomatology is usually much more severe in bilateral cases. Conclusions
This review paper illustrates that the growing variety of cortical malformations can be adequately classi®ed into one of the three categories described by Barkovich et al. [8]. High quality MRI is necessary for a detailed analysis of the cortical abnormalities and has become the gold standard in the assessment of (partial) epilepsy in children [46]. Nevertheless, the input of the clinician remains necessary to couple these neuro-anatomical data with e.g. family history, seizure characteristics, dysmorphic features, metabolic data and genetic ®ndings. Only then, well-delineated syndromes can be described and adequate counselling of the patients becomes possible, both in terms of outcome and genetics.
References 1. Aicardi J (1991) The agyria-pachygyria complex: a spectrum of cortical malformations. Brain Dev 13: 1±8 2. Appleton R, Gardner-Medwin D, Mendelow D (1991) Hemispherectomy for intractable seizures. Dev Med Child Neurol 33: 273±276 3. Barkovitch AJ, Jackson DE, Boyer RS (1989) Band heterotopias: a newly recognized neuronal migration anomaly. Radiology 171: 455±458 4. Barkovich A, Kjos B (1992) Schizencephaly: correlation of clinical ®ndings with MR characteristics. AJNR 13: 85±94 5. Barkovich AJ, Kjos BO (1992) Gray matter heterotopias: MR characteristics and correlation with developmental and neurologic manifestations. Radiology 182: 493±499 6. Barkovich AJ, Guerrini R, Battaglia G, Kalifa G, N'Guyen T, Parmeggiani A, Santucci M, Giovanardi-Rossi P, Granata T, D'Incerti L (1994) Band heterotopia: correlation of outcome with magnetic resonance imaging parameters. Ann Neurol 36: 609±617 7. Barkovich AJ, Kuzniecky RI (1996) Neuroimaging of focal malformations of cortical development. J Clin Neurophysiol 13: 481±494 8. Barkovich AJ, Kuzniecky RI, Dobyns WB, Jackson GD, Becker LE, Evrard P (1996) A classi®cation scheme for malformations of cortical development. Neuropediatrics 27: 59±63 9. Barkovich AJ, Kuzniecky RI, Bollen AW, Grant PE (1997) Focal transmantle dysplasia: a speci®c malformation of cortical development. Neurology 49: 1148±1152 10. Barkovich AJ, Peacock W (1998) Sublobar dysplasia: a new malformation of cortical development. Neurology 50: 1383± 1387 11. Battistella PA, Peserico A, Bertoli P, Drigo P, Laverda AM, Casara GL (1990) Hypomelanosis of Ito and hemimegalencephaly. Childs Nerv Syst 6: 421±423 12. Brunelli S, Faiella A, Capra V, Nigro V, Simeone A, Cama A, Boncinelli E (1996) Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet 12: 94±96 13. Chan S, Chin SS, Nordli DR, Goodman RR, DeLaPaz RL, Pedley TA (1998) Prospective magnetic resonance imaging identi®cation of focal cortical dysplasia, including the nonballoon cell subtype. Ann Neurol 44: 749±757 14. Chong SS, Pack SD, Roschke AV, Tanigami A, Carrozzo R, Smith ACM, Dobyns WB, Ledbetter DH (1997) A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum Mol Genet 6: 147±155 15. Chugani DC, Chuganu HT, Muzik O, Shah JR, Shah AK, Canady A, Magner TJ, Chakraborty PK (1998) Imaging epileptogenic tubers in children with tuberous sclerosis complex using alfa 11C methyl-L-tryptophan positron emission tomography. Ann Neurol 44: 858±866 16. Crino PB, Henske EP (1999) New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53: 1384±1390 17. Daumas-Duport C (1993) Dysembryoplastic neuroepithelial tumours. Brain Pathol 3: 283±295 18. Demaerel P, Lagae L, Casaer P, Baert AL (1998) MR of cerebellar cortical dysplasia. AJNR 19: 984±986 19. Des Portes V, Pinard GM, Billuart P, Vinet MC, Koulako, Carrie A, Gelot A, Dupuis E, Motte J, Berwald-Netter, Catala M, Kahn A, Beldjord C, Chelly J (1998) A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 92: 51±61 20. Dobyns WB, Stratton JB, Greenberg F (1984) Syndromes with lissencephaly. 1. Miller Dieker syndrome and Norman Roberts syndromes and isolated lissencephaly. Am J Med Genet 18: 509±526 21. Dobyns WB, Kirckpatrick JB, Hittner HM, Roberts RM, Kretzer FL (1985) Syndromes with lissencephaly. 2: Walker-
561
22.
23. 24.
25. 26.
27.
28. 29. 30. 31.
32. 33.
34. 35.
36. 37.
38. 39.
Warburg and cerebral ocular muscular syndromes and a new syndrome with type 2 lissencephaly. Am J Med Genet 22: 157± 195 Dobyns WB, Guerrini R, Czapansky-Beilman DK, Pierpont ME, Breningstall G, Yock DH, Bonanni P, Truwit CL (1997) Bilateral periventricular nodular heterotopia with mental retardation and syndactyly in boys: a new X-linked mental retardation syndrome. Neurology 49: 1042±1047 Duchowny MS, Resnick TJ, Alvarez L (1989) Dysplastic gangliocytoma and intractable partial seizures in childhood. Neurology 39: 602±604 Evrard P, Caviness VSJ, Prats-Vinas J, Lyon G (1978) The mechanism of arrest of neuronal migration in the Zellweger malformation and hypothesis based upon cytoarchitecture analysis. Acta Neuropathol 41: 109±117 Ferrer I, CatalaÁ I (1991) Unlayered polymicrogyria: structural and developmental aspects. Anat Embryol (Berl) 184: 517±528 Fogli A, Guerrini R, Moro F, Fernandez-Alvarez E, Livet MO, Renieri A, Cioni M, Pilz DT, Veggiotti P, Rossi E, Ballabio A, Carrozzo R (1999) Intracellular levels of the LIS1 protein correlate with clinical and neuroradiological ®ndings in patients with classical lissencephaly. Ann Neurol 45: 154±161 Fox JW, Lamperti ED, Eksioglu YZ, Hong SE, Feng Y, Graham DA, Scheer IE, Dobyns WB, Hirsch BA, Radtke RA, Berkovic SF, Huttenlocher PR, Walsh CA (1998) Mutations in ®lamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21: 1315±1325 Fryer AE, Connor JM, Povey S, Yates AD, Yater JR, Osborne JP (1987) Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1: 659±661 Fukuyama AY, Osawa M, Suzuki H (1981) Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathologic considerations. Brain Dev 3: 1±29 Germano IM, Sperber EF (1997) Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res 777: 219±222 Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA (1998) Doublecortin, a brain-speci®c gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92: 63±72 Granata T, Farina L, Faiella A, Cardini R, D'Incerti L, Boncinelli E, Battaglia G (1997) Familial schizencephaly associated with EMX2 mutation. Neurology 48: 1403±1406 Guerreiro MM, Andermann F, Andermann E, Palmini A, Hwang P, Homan HJ, Otsubo H, Bastos A, Dubeau F, Snipes GJ, Olivier A, Rasmussen T (1998) Surgical treatment of epilepsy in tuberous sclerosis. Strategies and results in 18 patients. Neurology 51: 1263±1269 Guerrini R, Dobyns WB (1998) Bilateral periventicular nodular heterotopia with mental retardation and frontonasal malformation. Neurology 51: 499±503 Guerrini R, Genton P, Bureau M, Parmeggiani A, Salas-Puig X, Santucci M, Bonanni P, Ambrosetto G, Dravet C (1998) Multilobar polymicrogyria, intractable drop attack seizures, and sleep-related electrical status epilepticus. Neurology 51: 504±512 Haltia M, Leivo I, Somer H, Pihko H, Paetou A, Kivela T, Tarkkanen A, Tome F, Engvall E (1997) Muscle-eye-brain disease: a neuropathological study. Ann Neurol 41: 173±178 Hattori M, Adachi H, Tsujimoto M, Arai H, Inoue K (1994) Miller-Dieker lissencephaly gene encodes a subunit of brain platelet activating factor acetylhydrolase. Nature 370: 216±218 Hayward JC, Titelbaum DS, Clancy RR, Zimmerman RA (1991) Lissencepahly-pachygyria associated with congenital cytomegalovirus infection. J Child Neurol 6: 109±114 Kandt RS, Haines L, Smith S, Northrup H, Garner RJ, Short MP, Dumars K, Roach ES, Steingold S, Wall S (1992) Linkage of an important gene locus for tuberous sclerosis to chromosome 16 marker for polycystic kidney disease. Nat Genet 2: 37±41
40. Kirckpatrick PJ, Honavar M, Janota I, Polkey CE (1993) Control of temporal lobe epilepsy following en bloc resection of low grade gliomas. J Neurosurg 78: 19±25 41. Kuzniecky R, Andermann F, Guerrini R (1993) Congenital bilateral perisylvian syndrome: study of 31 patients. The CBPS multicenter collaborative study. Lancet 341: 608±612 42. Kuzniecky R, Ho SS, Martin R, Faught E, Morawetz R, Palmer C, Gilliam F (1999) Temporal lobe developmental malformations and hippocampal sclerosis. Epilepsy surgical outcome. Neurology 52: 479±484 43. Landy HJ, Curless RG, Ramsay RE, Slater J, Ajmone-Marsan C, Quencer RM (1993) Corpus callosotomy for seizures associated with band heterotopia. Epilepsia 34: 79±83 44. Lo Nigro C, Chong SS, Smith ACM, Dobyns WB, Carrozzo R, Ledbetter DH (1997) Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet 6: 157±164 45. Matsumoto N, Pilz DT, Fantes JA, Kittikamron K, Ledbetter DH (1998) Isolation of BAC clones spanning the Xq22.3 translocation breakpoint in a lissencephaly patient with a de novo X;2 translocation. J Med Genet 35: 829±832 46. McBride MC, Bronstein KS, Bennett B, Erba G, Pilcher W, Berg MJ (1998) Failure of standard magnetic resonance imaging in patients with refractory temporal epilepsy. Arch Neurol 55: 346±348 47. Miller JQ (1993) Lissencephaly in two siblings. Neurology 13: 841±850 48. Palmini A, Andermann F, Aicardi J, Dulac O, Chaves F, Ponsot G, Pinard JM, Goutieres F, Livingston J, Tampieri D (1991) Diuse cortical dysplasia, or the `double cortex' syndrome: the clinical and epileptic spectrum in 10 patients. Neurology 41: 1656±1662 49. Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y (1991) Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann Neurol 30: 750±757 50. Palmini A, Gambardella A, Andermann F, Dubeau F, da Costa JC, Olivier A, Tampieri D, Gloor P, Quesney F, Andermann E (1995) Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 37: 476±487 51. Pinard JM, Motte J, Ciron C, Brian R, Andermann E, Dulac O (1994) Subcortical laminar heterotopia and lissencephaly in two families: a single X linked dominant gene. J Neurol Neurosurg Psychiatry 57: 914±920 52. Prayson RA, Estes ML (1995) Cortical dysplasia: a histopathologic study of 52 cases of partial lobectomy in patients with epilepsy. Hum Pathol 26: 493±500 53. Rakic P (1990) Principles of neuron cell migration. Experientia 46: 882±891 54. Redecker C, Lutzenburg M, Gressens P, Evrard P, Witte OW, Hagemann G (1998) Excitability changes and glucose metabolism in experimentally induced focal cortical dysplasias. Cereb Cortex 8: 623±634 55. Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, Caskey CT, Ledbetter DH (1993) Isolation of a Miller-Dieker lissencephaly gene containing G protein betasubunit-like repeats. Nature 364: 717±721 56. Reutens DC, Berkovic SF, Kalnins RM, McKelvie P, Saling MM, Fabinyi GCA (1993) Localised neuronal migration disorder and intractable epilepsy: a prenatal vascular aetiology. J Neurol Neurosurg Psychiatry 56: 314±316 57. Ross ME, Allen KM, Srivastava AK, Featherstone T, Gleeson JG, Hirsch B, Harding BN, Andermann E, Abdullah R, Berg M, Czapansky-Bielman D, Flanders DJ, Guerinni R, Motte J, Mira AP, Scheer I, Berkovic S, Scaravilli F, King RA, Ledbetter DH, Schlessinger D, Dobyns WB, Walsh CA (1997) Linkage and Physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain. Hum Mol Genet 6: 555±562
562 58. Santavuori P, Somer H, Sainio K, et al (1989) Muscle-eye-brain disease (MEB) Brain Dev 11: 147±153 59. Sisodiya SM, Free SL, Thom M, Everitt AE, Fish DR, Shorvon SD (1999) Evidence for nodular epileptogenicity and gender dierences in periventricular nodular heterotopia. Neurology 52: 336±341 60. Smith CD, Ryan SJ, Hoover SL, Baumann RJ (1996) Magnetic resonance imaging of the brain in Aicardi's syndrome. Report of 20 patients. J Neuroimaging 6: 214±221 61. Sprea®co R, Battaglia G, Arcelli P, Andermann F, Dubeau F, Palmini A, Olivier A, Villemure JG, Tampieri D, Avanzini G, Avoli M (1998) Cortical dysplasia. An immunocytochemical study of three patients. Neurology 50: 27±36 62. Sugita K, Ando M, Makino M, Takanashi J, Fujimoto N, Niimi H (1991) Magnetic resonance imaging of the brain in congenital rubella virus and cytomegalovirus infections. Neuroradiology 33: 239±242 63. Taylor DC, Falconer MA, Bruton CJ, Corsellis JAN (1971) Focal cortical dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34: 369±387 64. Van Bogaert P, David P, Gillain CA, Wikler D, Damhaut P, Scalais E, Nuttin C, Wetzburger C, Szliwowski HB, Metens T, Goldman S (1998) Perisylvian dysgenesis. Clinical, EEG, MRI
65.
66. 67. 68. 69.
70.
and glucose metabolism features in 10 patients. Brain 121: 2229±2232 van der Knaap MS, Smit LM, Barth PG, Catsman-Berrevoets CE, Brouwer OF, Begeer JH, deCoo IF, Valk J (1997) Magnetic resonance imaging in classi®cation of congenital muscular dystrophies with brain abnormalities. Ann Neurol 42: 50±59 Vinters HV, Kerfoot C, Catania M, Emelin JK, Roper SN, DeClue JE (1998) Tuberous sclerosis-related gene expression in normal and dysplastic brain. Epilepsy Res 32: 12±23 Vles JSH, Degraeuwe P, De Cock P, Casaer P (1985) Neuroradiological ®ndings in Jadassohn's naevus phakomatosis; a report of 2 cases. Eur J Pediatr 144: 290±294 Wallis DE, Muencke M (1999) Molecular mechanisms of holoprosencephaly. Mol Genet Metab 68: 126±138 Williams R, Swisher C, Jennins M, Ambler M, Caviness VJ (1984) Cerebroocular dysgenesis ``Walker-Warburg'' syndrome: neuropathologic and etiologic analysis. Neurology 34: 1531± 1541 Wyllie E, Comair YG, Kotagal P, Bulacio J, Bingaman W, Ruggieri P (1998) Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 44: 740±748